Trial NCT00626626

View at ClinicalTrials.gov 
Org. Study IDs: 25223

Last trial update was posted on 2018-04-25

MeSH Interventions

Alemtuzumab Clofarabine Cyclophosphamide

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Lymphoma Multiple Myeloma Myelodysplastic Syndromes Preleukemia

Other Conditions

Chronic Myelogenous Leukemia Hodgkin's Lymphoma Myelodysplastic Syndrome

Stopping Reasons

Investigator decision

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID